About Privi
Privi is a company based in Mumbai (India) founded in 1992 by Mahesh Babani and D B Rao was acquired by Fairfax India Holdings in July 2016. Privi has raised $18.56 million across 1 funding round from investors including Standard Chartered and Fairfax India Holdings. The company has 1,150 employees.
- Headquarter Mumbai, India
- Employees 1,150
- Founders Mahesh Babani, D B Rao
- Stage Public
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website privi.com
- Social LinkedIn
- Acquired by Fairfax India Holdings (Jul 2016)
- Legal Name Privi Speciality Chemicals Limited
- Annual Revenue₹2,122 Cr
FY 2025 · +19% YoY
- Net Profit₹185 Cr
FY 2025 · 9% margin
- EBITDA₹454 Cr
FY 2025 · 21% margin
- Total Equity Funding$18.56 M (USD)
in 1 rounds
- Latest Funding Round$18.56 M (USD), Series B
Mar 2011
- InvestorsStandard Chartered
& 1 more
- Employee Count1,150
- Acquired byFairfax India Holdings
(Jul 2016)
Associated legal entities of Privi
Privi operates through Privi Speciality Chemicals Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Privi Speciality Chemicals Limited Listed CIN L15140MH1985PLC286828 | Active | 25 May 1985 | Navi Mumbai, Maharashtra | ₹2,122 Cr | 701 | 8 | View details |
Funding Insights of Privi
Privi has successfully raised a total of $18.56M through 1 strategic funding round. The most recent funding activity was a Series B round of $18.56 million completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18.6M
- Total Rounds 1
- Last Round Series B — $18.6M
- First Round $18.6M
(Mar 2011)
- Investors Count 1
All 1 funding rounds of Privi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2011 | $18.6M | Series B | – | – |
2 investors in total: 2 institutional.
Investors in Privi
Privi has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Standard Chartered and Fairfax India Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on acquisitions | 2014 | fairfaxindia.ca | Toronto, Canada | |
Corporate, investment, wealth, and retail banking services are provided globally. | 1953 | sc.com | London, United Kingdom |
Investor details for Privi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Privi Speciality Chemicals Limited (Privi)
Privi Speciality Chemicals Limited is the primary company behind Privi. The board of Privi Speciality Chemicals Limited currently have 6 directors; the longest-serving is Mahesh Purshottam Babani, appointed in 2017. 36 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahesh Purshottam Babani DIN 00051162 | Managing Director | 11 May 2017 | 9 yrs 4 mo | Privi Speciality Chemicals Limited |
| Bhaktavatsala Rao Doppalapudi DIN 00356218 | Whole-time director | 11 May 2017 | 9 yrs 4 mo | Privi Speciality Chemicals Limited |
| Anurag Surana DIN 00006665 | Director | 13 Aug 2020 | 6 yrs 1 mo | Privi Speciality Chemicals Limited |
| Hemang Manhar Gandhi DIN 00008770 | Director | 07 Nov 2023 | 2 yrs 11 mo | Privi Speciality Chemicals Limited |
| Priyamvada Ashesh Bhumkar DIN 00726138 | Director | 25 Oct 2024 | 1 yr 11 mo | Privi Speciality Chemicals Limited |
| Naresh Madhu Tejwani DIN 00847424 | Director | 25 Oct 2024 | 1 yr 11 mo | Privi Speciality Chemicals Limited |
People of Privi
9 people are tracked at Privi (3 in leadership, 6 in team); the tracked headcount is 1,150.
| Name | Role | Group |
|---|---|---|
| Co-Founder & Managing Director | Leadership | |
D B Rao | Co-Founder | Leadership |
Ramkrishnan Balasubramanian | CEO | Leadership |
| Risk Mgmt Committee | Team | |
Anuradha Thakur | CSR Committee | Team |
| Risk Mgmt Committee | Team | |
| Risk Mgmt Committee | Team | |
Satya Kar | Sr. Manager-it | Team |
Chidambaram Ramaswamy | Group Leader - Research And Development | Team |
Complete people profiles for Privi
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Privi
Privi is a publicly listed company on the NSE with ticker symbol PRIVISCL in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 May 2015
- Listed onNSE: PRIVISCL
- Listed entityPrivi Speciality Chemicals Limited
- Exchange sectorProcess industries
- ISININE959A01019
- Share price₹3,430.10 (-0.47% on the day) · 2026-10-09
- Market capitalisation₹13,405 Cr
- Price to earnings38.3
- EPS (diluted, trailing year)₹89.55
- Dividend yield0.28%
- Volume (last session)43,161
Financials of Privi
Figures of Privi Speciality Chemicals Limited, the primary company behind Privi, for FY 2025. Revenue was ₹2,122 Cr (+19% year on year). Net profit was ₹185 Cr (9% margin). EBITDA was ₹454 Cr (21% margin). Revenue has grown at a compounded annual rate of +14% over three years and +5% over five years.
- ₹2,122 CrRevenue · FY 2025 · +19% YoY
- ₹185 CrNet profit · 9% margin
- ₹454 CrEBITDA · 21% margin
- ₹39.06 CrPaid-up capital
- 701Employees (provident fund records)
- +14%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹2,557 Cr | ₹328 Cr | ₹648 Cr |
| 2024 | ₹2,093 Cr | ₹187 Cr | ₹453 Cr |
| 2023 | ₹1,752 Cr | ₹94.9 Cr | ₹331 Cr |
| 2022 | ₹1,608 Cr | ₹22.2 Cr | ₹192 Cr |
| 2021 | ₹1,404 Cr | ₹97.4 Cr | ₹198 Cr |
Balance sheet, profit and loss, cash flow and ratios of Privi Speciality Chemicals Limited are on its company page.
Detailed financial statements for Privi
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Privi
4 dated milestones of Privi across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Privi is founded.
- Funding First funding round of $18.6M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Fairfax India Holdings.
Web traffic of Privi
The website of Privi (privi.com) receives about 7.3K visits a month.
- Monthly visits7.3K
▲ 2.5% vs previous month
Websites whose visitors overlap most with Privi. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pciplindia.com | pciplindia.com | 100% | – | #1,143,099 | – |
foreverest.net | foreverest.net | 95% | – | #1,456,821 | – |
monarchfragrances.com | monarchfragrances.com | 78% | – | – | – |
| tadimety.com | 78% | 1K | #15,315,313 | View details | |
| fragrance-india.com | 78% | – | #9,993,335 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Privi
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Privi
Complete news archive for Privi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Privi
10 companies that operate in the same segment as Privi (Chemical Preservatives & Ingredients), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Special chemicals for industrial applications are developed by Celanese. | 1918 | Irving, Texas, United States | – | USD 9.54 B | 12,160 | |
Flavor and fragrance ingredients are supplied to firms and retailers. | 1895 | Vernier, Geneve, Switzerland | – | USD 9.42 B | 16,940 | |
IFF is recognized as a global leader in flavors, fragrances, and biosciences. | 1889 | New York, New York, United States | – | USD 10.89 B | 22,400 | |
Manufacturer of aroma chemicals and esters | 1988 | Mumbai, Maharashtra, India | USD 12.3 M | USD 225.95 M | 488 | |
Pine chemicals, synthetic resins, and camphor products are manufactured. | 1996 | Mumbai, Maharashtra, India | – | USD 64.8 M | 349 | |
Keva is recognized as a leading fragrance and flavor manufacturer. | 1922 | Mumbai, Maharashtra, India | USD 44 M | USD 252.17 M | 635 | |
Innovative solutions in nutrition, health, and beauty are provided by dsm-firmenich. | 1869 | Kaiseraugst, Aargau, Switzerland | – | USD 10.61 B | 28,210 | |
Diversified chemical preservatives are manufactured for industrial applications. | 1989 | Ahmedabad, Gujarat, India | – | USD 210.29 M | 4,360 | |
Omega-3 fatty acids are manufactured and supplied by Mara. | 2012 | Dartmouth, Nova Scotia, Canada | USD 48.6 M | – | – | |
White oils are manufactured for pharmaceuticals, healthcare, and insulation uses. | 1992 | Mumbai, Maharashtra, India | – | USD 452.02 M | 361 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Privi
Privi was founded in 1992 and raised its 1st funding round 19 years after it was founded.
Privi is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ramkrishnan Balasubramanian is the current CEO of Privi.
Privi is a funded company, having raised a total of $18.56M across 1 funding round to date. The company's 1st funding round was a Series B of $18.56M, raised on Mar 2011.
Privi has 1,150 employees.
The primary company behind Privi, Privi Speciality Chemicals Limited, reported revenue of ₹2,122 Cr for FY 2025, up 19% year on year.
Privi was founded in 1992 in Mumbai, India, within the chemicals sector. Aroma and fragrance chemicals are produced through advanced manufacturing processes at facilities equipped with rigorous quality controls. An in-house RD center is operated to develop new products. Bulk supplies are delivered to major fragrance and flavor houses, as well as FMCG companies. Industry certifications related to quality, safety, and environmental standards are maintained.
Yes, Privi is publicly traded on NSE under the ticker symbol PRIVISCL.
Privi has 2 investors. Key investors include Standard Chartered, and Fairfax India Holdings.
Privi operates through Privi Speciality Chemicals Limited.
Yes. Privi was acquired by Fairfax India Holdings in July 2016.
The legal entities of Privi currently have 8 directors, including Mahesh Purshottam Babani, Anurag Surana, Bhaktavatsala Rao Doppalapudi and others.